Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Business, Policy & Funding › Business News › Quest, LabCorp Sued for Overbilling on Diagnostic Tests

Quest, LabCorp Sued for Overbilling on Diagnostic Tests

Apr 07, 2017
|
staff reporter

NEW YORK (360Dx) – Quest Diagnostics and Laboratory Corporation of America are being sued for allegedly overbilling patients for diagnostic tests.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

What's Popular?

In Business News

  1. Exact Sciences Stock Soars on New Data Around Pan-Cancer Liquid Biopsy Test

  2. FDA Grants Emergency Use Authorization for Jiangsu Well Biotech Coronavirus Antibody Test

  3. BARDA Awards $5.4M to Luminex for Expanded Respiratory Panel With Coronavirus Target

  4. Quotient Limited Gets FDA Emergency Use Authorization for Coronavirus Antibody Test

  5. LabCorp, Genfit Partner to Commercialize Liver Disease Diagnostic Test

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.